Investigating the relationship between Siponimod efficacy in secondary progressive multiple sclerosis and pathogenic Th cell populations

被引：0
|
作者：
Raveney, B. [1 ,2 ]
Katsumoto, A. [2 ,3 ]
Kurosawa, R. [3 ]
Lin, Y. [2 ,3 ]
Takahashi, Y. [3 ]
Okamoto, T. [2 ,3 ]
Oki, S. [1 ]
Sato, W. [1 ,2 ]
Yamamura, T. [1 ,2 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Kodaira, Tokyo, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Multiple Sclerosis Ctr, Kodaira, Tokyo, Japan
[3] Natl Ctr Neurol & Psychiat, Dept Neurol, Natl Ctr Hosp, Kodaira, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP0939
引用
收藏
页码：774 / 775
页数：2
相关论文
共 50 条
  • [21] Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report
    Rot, Uros
    Jerala, Miha
    Ledinek, Alenka Horvat
    Jakob, Gregor Brecl
    [J]. JOURNAL OF NEUROLOGY, 2024, 271 (08) : 4794 - 4812
  • [22] Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence
    Sabsabi, Sajida
    Mikhael, Elio
    Jalkh, Georges
    Macaron, Gabrielle
    Rensel, Mary
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 1307 - 1319
  • [23] Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis
    Wu, Qi
    Mills, Elizabeth A.
    Wang, Qin
    Dowling, Catherine A.
    Fisher, Caitlyn
    Kirch, Britany
    Lundy, Steven K.
    Fox, David A.
    Mao-Draayer, Yang
    [J]. JCI INSIGHT, 2020, 5 (03)
  • [24] Siponimod: A Review in Secondary Progressive Multiple Sclerosis (vol 34, pg 1191, 2020)
    Scott, Lesley J.
    [J]. CNS DRUGS, 2021, 35 (01) : 133 - 133
  • [25] The EXPAND study results: Safety and tolerability of siponimod in patients with secondary progressive multiple sclerosis
    Giovannoni, G.
    Bar-or, A.
    Cree, B.
    Fox, R.
    Gold, R.
    Vermersch, P.
    Pohlmann, H.
    Wallstrom, E.
    Wolf, C.
    Dahlke, F.
    Sidorenko, T.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 495 - 495
  • [26] Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
    Gajofatto, Alberto
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3153 - 3157
  • [27] Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
    Regner-Nelke, Liesa
    Pawlitzki, Marc
    Willison, Alice
    Rolfes, Leoni
    Oezalp, Sinem-Hilal
    Nelke, Christopher
    Koelsche, Tristan
    Korsen, Melanie
    Grothe, Matthias
    Groppa, Sergiu
    Luessi, Felix
    Engel, Sinah
    Nelles, Gereon
    Bonmann, Eckhard
    Roick, Holger
    Friedrich, Anke
    Knorn, Philipp
    Landefeld, Harald
    Biro, Zoltan
    Ernst, Michael
    Bayas, Antonios
    Menacher, Martina
    Akgun, Katja
    Kleinschnitz, Christoph
    Ruck, Tobias
    Ziemssen, Tjalf
    Pul, Refik
    Meuth, Sven G.
    [J]. NEUROLOGICAL RESEARCH AND PRACTICE, 2022, 4 (01):
  • [28] Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications
    Spiezia, Antonio Luca
    Scalia, Giulia
    Petracca, Maria
    Caliendo, Daniele
    Moccia, Marcello
    Fiore, Antonia
    Cerbone, Vincenza
    Lanzillo, Roberta
    Brescia Morra, Vincenzo
    Carotenuto, Antonio
    [J]. JOURNAL OF NEUROLOGY, 2024, 271 (07) : 4281 - 4291
  • [29] Analyses of the effect of baseline age on the efficacy and safety of siponimod in patients with active secondary progressive multiple sclerosis from the EXPAND study
    Hua, L. H.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Cox, G. M.
    Cree, B. Ac
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 551 - 552
  • [30] Safety and efficacy of siponimod in patients with active secondary progressive multiple sclerosis identifying as Hispanic from the phase 3 EXPAND study
    Cohan, S.
    Hua, L. H.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Cox, G. M.
    Coyle, P. K.
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 590 - 591
12345